F. David Rollo, MD, Ph.D., FACC, FACNP is recognized by Continental Who's Who as a Pinnacle Professional

SARATOGA, Calif., Nov. 14, 2014 /PRNewswire/ -- F. David Rollo, MD, Ph.D., FACC, FACNP is recognized by Continental Who's Who as a Pinnacle Professional in the field of Medicine as a result of his role as President of Cell Point, LLC.

Cell Point is a privately held biotechnology company with offices in Centennial, Colorado, Houston and Saratoga, California. The company's five technology platforms, ethylenedicysteine drug conjugate technology ("EC Technology"), In-Situ Hydrogel ("In Situ Hydrogel Technology"), tetraazacyclopentadecane technology ("N4 Technology"), oligosaccharide conjugate technology ("Dual Agent Technology") and mechanism-based targeted pancreatic beta cell technology ("Beta Cell Technology") are being developed to create new radiodiagnostic imaging agents, new intra-nuclear therapeutic agents, and high yield delivery systems for the administration of local regional radio/chemotherapy.

As President, Dr. Rollo has an array of knowledge in cardiology and non-invasive ways of diagnostic imaging including PET scans, echocardiography of the heart, and angiography. He has been the President of Cell Point since 2006 and specializes in the development of universal oncology, cardiology, stroke and diabetes molecular imaging agents, and intranuclear metallic therapeutics. Dr. Rollo is Board Certified by the American Board of Nuclear Medicine and Cardiology, and has served as a manuscript reviewer for 6 esteemed medical journals, as well as co-editing eight textbooks, publishing over 270 articles and giving more than 500 presentations. Throughout the course of his illustrious career, Dr. Rollo has received nearly 60 awards, honors and grants.

Moreover, Dr. Rollo is a fellow of the American College of Cardiology and a fellow of the American College of Nuclear Physicians. In addition, he has served on the Board of Directors of eleven companies, and five of those companies went public. The five companies are Cambridge Heart, KBL Healthcare, NeoRx Corporation, Raytel Medical Corporation, and ADAC Labs.

Dr. Rollo earned his M.D. from Upstate Medical Center in Syracuse, and a Ph.D. in Physics from The Johns Hopkins Medical Institutions. He also holds a Master of Science degree in Radiological Physics from University of Miami.

For more information, please visit www.cellpointweb.com.

Contact: Robert Basilin, 516-825-5634, [email protected]

SOURCE Continental Who's Who

Related Links

http://www.continentalwhoswho.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED